Kensington Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.96M Sell
16,454
-1,161
-7% -$397K 2.59% 12
2026
Q1
$6.2M Sell
17,615
-456
-3% -$163K 2.98% 8
2025
Q4
$5.91M Buy
18,071
+990
+6% +$314K 2.4% 8
2025
Q3
$4.82M Buy
17,081
+516
+3% +$150K 1.96% 16
2025
Q2
$4.63M Buy
16,565
+509
+3% +$144K 1.98% 15
2025
Q1
$5M Buy
16,056
+1,006
+7% +$297K 2.22% 13
2024
Q4
$3.92M Buy
15,050
+651
+5% +$193K 1.64% 19
2024
Q3
$4.64M Buy
14,399
+209
+1% +$68.4K 1.94% 13
2024
Q2
$4.43M Buy
14,190
+667
+5% +$196K 1.96% 13
2024
Q1
$3.84M Buy
13,523
+1,197
+10% +$350K 1.76% 16
2023
Q4
$3.55M Buy
12,326
+1,792
+17% +$488K 1.86% 15
2023
Q3
$2.83M Buy
10,534
+580
+6% +$145K 1.76% 17
2023
Q2
$2.21M Buy
9,954
+876
+10% +$203K 1.4% 25
2023
Q1
$2.19M Buy
9,078
+176
+2% +$43.2K 1.66% 20
2022
Q4
$2.34M Buy
8,902
+113
+1% +$30.3K 1.84% 15
2022
Q3
$1.98M Buy
8,789
+435
+5% +$105K 1.67% 19
2022
Q2
$2.03M Sell
8,354
-144
-2% -$35.3K 1.73% 17
2022
Q1
$2.06M Buy
8,498
+422
+5% +$97K 1.36% 24
2021
Q4
$1.82M Buy
+8,076
New +$1.7M 1.06% 44
2021
Q2
$1.94M Buy
7,972
+301
+4% +$74K 1.33% 25
2021
Q1
$1.91M Buy
7,671
+861
+13% +$205K 1.44% 22
2020
Q4
$1.57M Buy
+6,810
New +$1.57M 1.29% 30

Other funds holding AMGN

Kensington Investment Counsel's AMGN Position: Q2 2026 in Review

Kensington Investment Counsel reduced its Amgen (AMGN) stake by 6.6% in Q2 2026, selling an estimated $397K and leaving 16,454 shares worth $5.96M. The position accounts for 2.59% of the portfolio, ranked #12.

Kensington Investment Counsel first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.2M in Q1 2026. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kensington Investment Counsel held 16,454 shares of Amgen worth $5.96M as of Q2 2026.
  • Kensington Investment Counsel sold 1,161 Amgen shares in Q2 2026, an estimated $397K.
  • Amgen made up 2.59% of Kensington Investment Counsel's portfolio in Q2 2026, its #12 holding.
  • Kensington Investment Counsel first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • Kensington Investment Counsel's Amgen position peaked at $6.2M in Q1 2026.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kensington Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.